Skip to main content

Disease and Therapeutic Response Modeling Program

Fueled by foundational teaching and innovative research, the Disease and Therapeutic Response Modeling Program equips young scientists with diverse experiences in the design, application and interpretation of quantitative approaches that drive the evolution of medical therapies. 

Disease and Therapeutic Response Modeling and Simulation Symposium
The 11th Annual Indiana CTSI Disease and Therapeutic Response Modeling and Simulation Symposium will feature interactive networking and trainee-focused sessions and talks from international pharmacometrics experts.

Virtual Symposium

Register now for the 11th Annual Indiana CTSI Disease and Therapeutic Response Modeling and Simulation Symposium. 

Please direct any questions or concerns to director Sara Quinney, PhD or Administrative Generalist Coordinator, Megan Creasser.

Register for the Disease and Therapeutic Response Modeling and Simulation Symposium

With the growth of model-informed drug discovery, the roles of quantitative pharmacologists and pharmacometricians are rapidly growing in the pharmaceutical industry. Since 2009, the Disease and Therapeutic Response Modeling Program (DTRMP) at Indiana University School of Medicine has trained over 30 postdoctoral fellows and graduate students, the majority of whom continue to play important research and leadership roles within the pharmaceutical industry. 

The DTRMP also plays a critical role in the Division of Clinical Pharmacology’s T32 Training Program, with most fellows attending didactic sessions offered on population pharmacokinetic/pharmacodynamic or physiologically based pharmacokinetic modeling, and many participating in pharmacometric-oriented research projects. Additionally, graduate students from Purdue University’s Department of Pharmacy Practice participate in the didactic sessions and are often actively mentored by DTRMP faculty.


Want to know more?

Interested in the DTRMP? Contact us for more information.

Contact Dr. Sara Quinney

Disease and Therapeutic Response Modeling Program Fellowship

  • Director

    Sara Quinney, PhDis the current Director of the Disease and Therapeutic Response Modeling Program.

    Dr. Quinney serves as a standing member of the IU Simon Comprehensive Cancer Center Cancer Drug Development Working Group, is PI for the MPRINT DMKRCC (supporting pharmacometric modeling in maternal and pediatric therapeutics) and provides support to Drug Think Tank investigators. Additionally, the DTRMP supports PK/PD study design and analyses for multiple clinical studies.

    For additional information on the DTRMP program, please contact Dr. Quinney.

  • Didactic Courses
    In addition to the introductory Pharmacokinetics and Pharmacodynamics course that is part of the Clinical Pharmacology T32 didactics training program, the DTRMP has developed two advanced pharmacometrics courses: Physiologically-Based Pharmacokinetics and Population Pharmacokinetics. These courses are offered every-other year. Purdue University Department of Pharmacy Practice offers credit for these courses to their graduate students. Additionally, we offer a short-course in biostatistics for clinical pharmacologists. These courses utilize experts from the pharmaceutical industry to provide fundamental knowledge of pharmacometrics as well as cutting-edge applications. 

     

    Course Name Director(s)
    Clinical Pharmacokinetics and Pharmacodynamics Richard Bergstrom
    Sara Quinney
    Brian Overholser
    Kevin Sowinski
    Physiologically Based Pharmacokenetic Modeling Sara Quinney
    Population Pharmacokinetics Michael Heathman
    Biostatistics for Clinical Pharmacologists Richard Bergstrom


  • Annual DTRM Symposium

    The DTRMP hosts an annual symposium, featuring international experts in pharmacometrics and quantitative sciences from academia, industry, and regulatory agencies. In 2021, the symposium was held virtually over three days and included a number of interactive breakout sessions to provide networking and mentorship opportunities for trainees.

    The 2022 symposium will be held February 16-18, 2022.  Confirmed speakers include Sander Vinks (University of Cincinnati), Christina Frederich (Rosa), Craig Goergen (Purdue University), Sebastian Wicha (University of Hamburg), Rada Savic (UCSF), Allison Hill (John Hopkins), lan Pearlson (Los Alamos Laboratories), Denise Kirschner (University of Michigan), and speakers from Eli Lilly, Abbvie, Metrum Research Group, and the FDA. Additionally, the symposium will feature rapid fire talks from trainees and mentoring roundtables.

  • Supporting Drug Development and Clinical Studies
    The DTRMP plays a critical collaborative role in numerous drug development and personalized therapeutics initiatives at Indiana University School of Medicine.

    Services provided by the DTRMP include:

    • In silico predictions; in vitro/in vivo extrapolation
    • Preclinical study design – dosing, optimal sampling times
    • Preclinical data assessment – bioavailability, clearance, volume, half-life
    • Clinical study design – dosing, optimal sampling
    • Pharmacokinetic-pharmacodynamic modeling of preclinical & clinical data
    • Clinical data assessment – sources of inter-individual variability
    • Noncompartmental, population and mechanistic PK/PD modeling
    • MODEL-AD and TREAT-AD programs